A Longitudinal Follow-Up Study on Predicting Major Depressive Disorder From Rest-Activity Rhythm Profiles

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorChinese University of Hong Kong

About this trial

This proposed study will be a longitudinal follow-up study of a case-control study of 160 participants (CREC Ref: 2023.234). This study aims to follow up on the trajectory of depression and rest-activity rhythm (RAR) disruptions, as well as examine their association over time. The investigators aim to identify distinctive RAR profiles of MDD using the data from the original project and hypothesize that two or more groups will be identified based on individual RAR variables using cluster analysis. The investigators hypothesize that significant differences in depressive symptom severity, sleep quality, and other outcome measures collected in this follow-up will be found between the clustered groups. Individuals exhibiting the most disrupted RAR profiles are hypothesized to have the greatest deterioration in depression symptom severity and other outcome measures. The investigators also hypothesize that people persisting with MDD will exhibit greater disruptions in RAR compared to those without MDD at the follow-up. Furthermore, the investigators will examine whether individual RAR parameters are longitudinally associated with changes in depression symptom severity and other outcome measures.

Eligibility criteria

Qualifiers

Hong Kong residents aged 18 to 70 years

Chinese language fluency

Accessibility to an Internet-enabled mobile device

A willingness to provide informed consent and comply with the study protocol

Disqualifiers

Severe medical or neurocognitive disorders that make participation unsuitable

History of electroconvulsive therapy (ECT)

An unstable use of psychotropic drugs (medication use has to remain stable for at least 6 weeks before baseline assessment)

Current involvement in any psychological treatment program that targets depression and/or sleep problems

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

160 Participants
are grouped into 2 trial groups